MW

Michael Widmann

Investor at Anterra Capital

Boston, Massachusetts

Overview 

Michael Widmann is a VC at Anterra Capital in Boston, Massachusetts, specializing in investing in stages ranging from Series B to Seed in sectors like AgTech and FinTech. With a background in Protein Engineering and Environmental Toxicology, he has experience at top firms like L.E.K. Consulting and Bayer, and holds an MBA from Harvard Business School. Highlights of Michael's career include his role as an Investor at Anterra Capital and his diverse experience in consulting, business development, and inhouse consulting at leading organizations, showcasing his expertise in various industries and sectors.

Work Experience 

A

AbbVie

  • Associate Director, Portfolio Strategy & Analytics

    2025 - Current

AbbVie is a pharmaceutical company that discovers, develops, and markets medicines.

Raised $15,000,249,999.00.

abbvie.com
AC

Anterra Capital

  • Associate

    2022 - 2025

    Early-stage biotech / life sciences investing. Seed - Series B. Sample technologies evaluated: Drug Discovery, Therapeutics, Platform Technologies, Biotech, Healthtech, Nutrition, Crop Science, Animal Health. Portfolio Support: GTM Strategy, Growth Strategy, Pipeline Prioritization, Indication Prioritization, Capital Allocation, Financial Modeling, NPV Analysis, Scenario Planning, Enterprise Strategy, Governance, Hiring.

BY

Berkeley Yeast

  • MBA Intern

    2023 - 2023

    GTM Strategy, R&D Strategy, Fundraising & Governance.

Berkeley Yeast bioengineers yeast strains that elevate fermentation for brewers and beyond.

Raised $12,149,998.00 from Anterra Capital and Finistere Ventures.

berkeleyyeast.com
LC

L.E.K. Consulting

  • Consultant

    2021 - 2022

    Life Sciences Team Project Lead, managing 3-5 team members Multiple strategy projects including: R&D portfolio prioritizations, supply chain / clinical trial strategy for a covid-19 vaccine manufacturer, M&A growth strategy for major MedTech company, Asset Screen for large Biopharma company 15+ due diligences across life sciences Skills: Scenario forecasting, NPV analysis & market modeling, GTM strategy, new product launch planning (NPP), revenue forecast, stakeholder management, storytelling & answer development, executive communication, cross-functional collaboration, competitive analysis, market landscape evaluation, data-driven decision-making, portfolio prioritization, Excel & PowerPoint Firm Involvement: Green Committee Head (global lead of all sustainability initiatives and carbon offsetting), Pan Mass Challenge Team Captain, Pride Committee

  • Senior Associate Consultant

    2020 - 2021

  • Associate Consultant

    2020 - 2020

  • Associate

    2018 - 2020

R

RapidSOS

  • Business Development Fellow

    2018 - 2018

RapidSOS is an intelligent safety platform that connects devices, apps, and sensors for safety agents.

Raised $355,730,006.00 from Acrew Capital, Manhattan Venture Partners (MVP), Harmonic Growth Partners, NightDragon, BAM Elevate, BlackRock, Insight Partners, BAM Elevate, Playground Global and Forté Ventures.

rapidsos.com
B

Bayer

  • Inhouse Consulting Intern

    2017 - 2017

Education 

Articles About Michael

Relevant Websites